‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
Intranasal naloxone spray could reduce opioid-related deaths
Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...
Montelukast use sparks suicide concerns
With reports of children as young as 5 attempting suicide and low efficacy, here’s how pharmacists can approach montelukast supply.
A practical guide to delivering COVID-19 vaccinations
With the beginning of the COVID-19 vaccine roll out this week, pharmacists need to ensure both their staff and practice are prepared for delivery.
Tips for becoming a GP pharmacist
A practical guide to upskilling, developing a role and finding the right general practice to match your experience.
Expect staggering pharmacy job losses, says new report
The 60-day dispensing policy is predicted to have enormous impacts on community pharmacy and vulnerable Australians.
Risk factors for long-term opioid misuse
Younger age, substance dependence, mental health histories and higher opioid doses are the risk factors most consistently associated with problematic opioid use
